ARCHIVES

Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Pollock Named Director of Surgical Oncology At Ohio State Comprehensive Cancer Center

May 8, 2013

Program Announcement In Preventative Oncology

May 21, 1982

NCI Advisors Approve Plans To Continue Current Research Programs.

July 3, 2008

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

July 26, 2013

Moves Forward With Approval From BSA

November 22, 2013

Breast, Ovarian Cancers Detected Early In Women At High Hereditary Risk

March 29, 2002